共 86 条
[1]
Alba AC(2017)Discrimination and calibration of clinical prediction models: users’ guides to the medical literature JAMA 318 1377-1384
[2]
Agoritsas T(2017)Randomized, noncomparative, phase II trial of early switch from docetaxel to cabazitaxel or vice versa, with integrated biomarker analysis, in men with chemotherapy-naïve, metastatic, castration-resistant prostate cancer J Clin Oncol 35 3181-3188
[3]
Walsh M(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[4]
Antonarakis ES(2019)Establishing a prediction model for prostate cancer bone metastasis Int J Biol Sci 15 208-220
[5]
Tagawa ST(2011)Epigenetic regulation of prostate cancer Clin Epigenetics 2 151-169
[6]
Galletti G(2019)Association between drug treatments for patients with osteoporosis and overall mortality rates: a meta-analysis JAMA Intern Med 179 1491-1500
[7]
Bray F(2019)A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies Eur Urol 75 506-514
[8]
Ferlay J(2017)Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: interim results from the Multicenter Prospective PRO-IMPACT study Cancer 123 2850-2859
[9]
Soerjomataram I(2019)Development and validation of a SEER-based prognostic nomogram for patients with bone metastatic prostate cancer Medicine (baltimore) 98 1364-1370
[10]
Chen S(2008)How to build and interpret a nomogram for cancer prognosis J Clin Oncol 26 157-390